Peter H O'Donnell

19PUBLICATIONS
90CO-AUTHORS
Pharmacology and pharmaceutical sciences not elsewhere classifiedMedical molecular engineering of nucleic acids and proteinsGene and molecular therapyCancer geneticsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jan 29, 2026
Dear Doctor: We Still Have No Idea of What Dose of Capecitabine You Should Prescribe.

Mark J Ratain, Peter H O'Donnell

|Aug 23, 2025
Results of the ACCOuNT Trial: A Multi-Institutional Prospective Pharmacogenomics Implementation Trial for African American Inpatients.

Zhong Huang, Kevin J O'Leary, Edith A Nutescu

|Jun 28, 2025
Impact of First-of-Its-Kind Patient-Facing Pharmacogenetics Tool on Dosing Decisions and Treatment Outcomes.

Youngwoo Cho, Sami Elahi, Matthew M Jack

|Apr 08, 2025
Pharmacogenomics of chemotherapy induced peripheral neuropathy using an electronic health record-derived definition: a genome-wide association study.

Michael K Jones, Andrew Nicklawsky, Jonathan Shortt

|Mar 04, 2025
A National Study Among Diverse US Populations of Exposure to Prescription Medications with Evidence-Based Pharmacogenomic Information.

Loren Saulsberry, Jacob C Jameson, Robert D Gibbons

|Mar 27, 2024
A Phase I Trial of Enzalutamide Plus Selective Glucocorticoid Receptor Modulator Relacorilant in Patients with Metastatic Castration-Resistant Prostate Cancer.

Kunal B Desai, Anthony V Serritella, Walter M Stadler

Pageof 4